LSDV-Vectored SARS-CoV-2 S and N Vaccine Protects against Severe Clinical Disease in Hamsters

The SARS-CoV-2 pandemic demonstrated the need for potent and broad-spectrum vaccines. This study reports the development and testing of a lumpy skin disease virus (LSDV)-vectored vaccine against SARS-CoV-2, utilizing stabilized spike and conserved nucleocapsid proteins as antigens to develop robust...

Descripción completa

Detalles Bibliográficos
Autores principales: de Moor, Warren R. J., Williamson, Anna-Lise, Schäfer, Georgia, Douglass, Nicola, Gers, Sophette, Sutherland, Andrew D., Blumenthal, Melissa J., Margolin, Emmanuel, Shaw, Megan L., Preiser, Wolfgang, Chapman, Rosamund
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383203/
https://www.ncbi.nlm.nih.gov/pubmed/37515096
http://dx.doi.org/10.3390/v15071409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383203/
https://www.ncbi.nlm.nih.gov/pubmed/37515096
http://dx.doi.org/10.3390/v15071409

Ejemplares similares